Andere talen scPharmaceuticals Inc.

Aandelen

SCPH

US8106481059

Geschatte realtime Cboe BZX Andere beurzen 17:35:42 26-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,97 ^USD	+0,25%		-2,97%	-37,48%

14/05	Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024
14/05	ScPharmaceuticals Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ScPharmaceuticals to Present at the Jefferies Global Healthcare Conference	29/05
ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
ScPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	14/05
ScPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference	13/05
ScPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024	07/05
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector Injection	25/04
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection	24/04
ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection	24/04
ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	13/03
ScPharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024	06/03
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	28/02
ScPharmaceuticals Expects Higher Q4 Product Sales	04/01
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue	04/01
ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023	04/01
ScPharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update	08/11
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	01/11
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	31-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen scPharmaceuticals Inc.

Aandelen

SCPH

US8106481059

Andere talen

Filters